Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers: A Randomized-Controlled Trial

NCT04438837 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.

NCT NCT04438837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04438837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers: A Randomized-Controlled Trial
Lead sponsor
Rambam Health Care Campus
Phase
Not applicable
Overall status
Unknown status
Start date
July 31, 2020
Completion date
June 30, 2022
Enrollment
582 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus disease 2019 (covid-19), post-exposure prophylaxis